FSSAI approved
GMP certified facility
No harmful carcinogens
Tested for purity and potency
Early stage Kit
₹5,097
Oncoceuticals and onco-nutraceuticals are indispensable in controlling prognostic cancers in a noninvasive manner.
The hall marks of Early Stage, Precancerous or Zero Stage cancers can be characterized by differentiating cellular inflammation,
phenotype metabolism, dysbiosis, signaling configurations, mutations, deformation, instability and mitochondrial dysfunction.
Product Overview
Benefits
Kills deforming differentiating malignant cells
Prevents the spread to nearby tissues
Protects from genomic instability
Regulates oncometabolic modifications
Key Mechanisms in Anti-Cancer Therapeutics
- Anti-neoplastic genome alterations
- Anti-onco inflammation
- Anti-oncogenic stem cell proliferation
- Oncolytic trans differentiation
- Anti-oncogenic epigenetic modifiers
Dosage & Duration
BRECAN : 1-0-1
Morning-Preferably on empty stomach Avoid coffee or tea for at least 45-60 mins One can have as much water May have coffee after breakfast
ONCO-3 : 0-1-1
Preferably after or along with the food Avoid coffee/ tea or dessert for at least for an hour
Prolung : 0-1-0
Late afternoon- Preferably 3hrs after lunch Avoid coffee/ tea or dessert for at least 60 mins
Observable Benefits and Key Mechanisms
- Observable and monitorable benefits
- Reprogramming mitochondrial metabolism
- Avoiding Immune Destruction
- Regulation of Cell-Cell signaling
Optimized Usage Protocols for Maximum Potency and Safety
- Usage protocols for maximizing potency
- Dosages are based on case studies
- Suitable for daily use
- Safer dosage for long term use
Who Should Take it?
Suffering from
- Early-stage prognostic cancers
- Precancerous conditions
- Hereditary history of cancers
- Tumor surgery
- Under remission
Media Coverage
